e.g. Tata motors, Reliance MF, 500570

Glenmark Pharmaceuticals Ltd - Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th September, 2025

Download announcement < Back
26 Sep 2025
The Board approved Interim Dividend of Rs. 2.50 per equity shares on face value of Re. 1/- per equity shares for the Financial Year 2025-26 and reconstitution of Committees.
View all announcements for Glenmark Pharmaceuticals Ltd Source: BSE India

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback